OWC Pharmaceutical Research Corp., through its wholly-owned Israeli subsidiary, One World Cannabis Ltd., (collectively 'OWC' or the 'Company') conducts medical research and clinical trials to develop cannabis-based pharmaceuticals and treatments for conditions including multiple myeloma, psoriasis, fibromyalgia, PTSD, and migraines. OWCP is also developing unique and effective delivery systems and dosage forms of medical cannabis. All OWC research is conducted at leading Israeli hospitals and scientific institutions and led by internationally renowned investigators.
Looking for a particular OWC Pharma employee's phone or email?
The OWC Pharma annual revenue was $5 million in 2026.
OWC Pharma is based in Ramat Gan, L3.
The NAICS codes for OWC Pharma are [3254, 32541, 325, 32].
The SIC codes for OWC Pharma are [28, 283].